Literature DB >> 24436132

TERT promoter mutations predict worse survival in laryngeal cancer patients.

Yiping Qu1, Siwen Dang, Kexia Wu, Yuan Shao, Qi Yang, Meiju Ji, Bingyin Shi, Peng Hou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24436132     DOI： 10.1002/ijc.28728

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  24 in total

1.  BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.

Authors:  Mingzhao Xing; Rengyun Liu; Xiaoli Liu; Avaniyapuram Kannan Murugan; Guangwu Zhu; Martha A Zeiger; Sara Pai; Justin Bishop
Journal:  J Clin Oncol       Date:  2014-07-14       Impact factor: 44.544

Review 2.  [Invasion and metastasis mechanism of human papillomavirus in head and neck squamous cell carcinomas].

Authors:  Guang-Xue Cui; Xiao-Lei Gao; Xin-Hua Liang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-10-01

Review 3.  Telomerase promoter mutations in cancer: an emerging molecular biomarker?

Authors:  João Vinagre; Vasco Pinto; Ricardo Celestino; Marta Reis; Helena Pópulo; Paula Boaventura; Miguel Melo; Telmo Catarino; Jorge Lima; José Manuel Lopes; Valdemar Máximo; Manuel Sobrinho-Simões; Paula Soares
Journal:  Virchows Arch       Date:  2014-07-22       Impact factor: 4.064

4.  Association of Relative Leucocyte Telomere Length and Gene Single Nucleotide Polymorphisms (TERT, TRF1, TNKS2) in Laryngeal Squamous Cell Carcinoma.

Authors:  Paulius Vaiciulis; Rasa Liutkeviciene; Vykintas Liutkevicius; Alvita Vilkeviciute; Greta Gedvilaite; Virgilijus Uloza
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

Review 5.  Age-specific oncogenic pathways in head and neck squamous cell carcinoma - are elderly a different subcategory?

Authors:  Martine Froukje van der Kamp; Gyorgy Bela Halmos; Victor Guryev; Peter Laszlo Horvatovich; Ed Schuuring; Bernardus Franciscus Augustinus Maria van der Laan; Bert van der Vegt; Boudewijn Evert Christiaan Plaat; Cornelia Johanna Verhoeven
Journal:  Cell Oncol (Dordr)       Date:  2022-01-11       Impact factor: 6.730

6.  TERT Genetic Mutations as Prognostic Marker in Glioma.

Authors:  Peiliang Geng; Xiaoxin Zhao; Juanjuan Ou; Jianjun Li; Rina Sa; Houjie Liang
Journal:  Mol Neurobiol       Date:  2016-05-20       Impact factor: 5.590

Review 7.  Understanding TERT Promoter Mutations: A Common Path to Immortality.

Authors:  Robert J A Bell; H Tomas Rube; Ana Xavier-Magalhães; Bruno M Costa; Andrew Mancini; Jun S Song; Joseph F Costello
Journal:  Mol Cancer Res       Date:  2016-03-03       Impact factor: 5.852

8.  TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.

Authors:  Paolo Boscolo-Rizzo; Silvia Giunco; Enrica Rampazzo; Martina Brutti; Giacomo Spinato; Anna Menegaldo; Marco Stellin; Monica Mantovani; Luigia Bandolin; Marco Rossi; Annarosa Del Mistro; Giancarlo Tirelli; Angelo Paolo Dei Tos; Angela Guerriero; Monia Niero; Maria Cristina Da Mosto; Jerry Polesel; Anita De Rossi
Journal:  J Cancer Res Clin Oncol       Date:  2020-01-20       Impact factor: 4.553

9.  Change of telomerase activity in peripheral blood of patients with head and neck squamous cell carcinoma pre and post curative treatment.

Authors:  M S Ganesh; Geeta S Narayanan; Rishabh Kumar
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-01

10.  The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.

Authors:  Luc G T Morris; Raghu Chandramohan; Lyndsay West; Ahmet Zehir; Debyani Chakravarty; David G Pfister; Richard J Wong; Nancy Y Lee; Eric J Sherman; Shrujal S Baxi; Ian Ganly; Bhuvanesh Singh; Jatin P Shah; Ashok R Shaha; Jay O Boyle; Snehal G Patel; Benjamin R Roman; Christopher A Barker; Sean M McBride; Timothy A Chan; Snjezana Dogan; David M Hyman; Michael F Berger; David B Solit; Nadeem Riaz; Alan L Ho
Journal:  JAMA Oncol       Date:  2017-02-01       Impact factor: 31.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.